| GTO ID | GTC3339 |
| Trial ID | NCT05738447 |
| Disease | Liver Cancer |
| Therapy | mRNA vaccine |
| Treatment | HBV mRNA Vaccine |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Study of mRNA Vaccine for Patients With HBV-positive Advanced Hepatocellular Carcinoma |
| Year | 2023 |
| Country | China |
| Company sponsor | West China Hospital |
| Other ID(s) | 2022-1371 |
| Cohort 1 | |||||||
|
|||||||